Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Compugen (CGEN) Shares Outstanding (Diluted Average) (2017 - 2025)

Compugen's Shares Outstanding (Diluted Average) history spans 14 years, with the latest figure at $160.0 for Q2 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 60.0% to $160.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $160.0, a 60.0% increase, with the full-year FY2015 number at $50.5 million, up 0.76% from a year prior.
  • Shares Outstanding (Diluted Average) hit $160.0 in Q2 2025 for Compugen, up from $100.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for CGEN hit a ceiling of $230.0 in Q2 2021 and a floor of $100.0 in Q2 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $184.0 across 5 years, with a median of $210.0 in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 52.38% in 2024 and later skyrocketed 60.0% in 2025.
  • Tracing CGEN's Shares Outstanding (Diluted Average) over 5 years: stood at $230.0 in 2021, then decreased by 4.35% to $220.0 in 2022, then dropped by 4.55% to $210.0 in 2023, then plummeted by 52.38% to $100.0 in 2024, then surged by 60.0% to $160.0 in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CGEN at $160.0 in Q2 2025, $100.0 in Q2 2024, and $210.0 in Q2 2023.